usa clinic

When general population speak of contemporary medicine, accuracy plays one of the most significant roles and human lives are directly dependent on it. Likewise, any researches pertaining to medicine are required to meet the top standards. The issue today is that any outcomes of researches can be published online and used as a reference without being precisely checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this issue and decided to create an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The major principle of this journal is related to Altmetric scores that are used as a quality indicator. That helps both readers and authors to verify publications with Altmetric Article Reports that generate “real-time feedback containing data summary related to a particular publication". Oncotarget website has a complete publications list with corresponding scores higher than 1

  Oncotarget Volume 11, Issue 29 reported that Immunosuppressive chemoresistance is a major burden in lung cancer. Recent data reveal that long noncoding RNAs present in the lung tumor microenvironment are implicated in chemoresistant-related immune deregulation, and metastasis but their exact pathogenic role is still unknown. In this study, the Oncotarget authors investigate the role of lncRNA PCAT-1 in chemoresistant immunosuppression and its involvement in tumor stroma remodeling. Findings reveal PCAT-1 to regulate Kras-related lung chemoresistance through increased expression of the immunosuppressive micrornas miR-182/miR217 in lung tissues, thus promoting a pre-metastatic niche formation and a subsequent increase in lung metastatic burden. Subsequent PCAT-1 knockdown impaired CAF-mediated stromal activation, and reversed chemoresistance and tumor growth in vivo. Overall, these findings demonstrate the versatile roles of PCAT-1 in sustaining lung immunosuppressive neoplasia throu

When public mention modern medicine, precision plays one of the most important roles and people’s lives are directly dependent on it. Likewise, any researches pertaining to medicine are required to comply with the highest standards. The challenge today is that any conclusions of researches can be posted online and used as a reference without being thoroughly verified and approved. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and attempted to create an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been established back in 2010. The main principle of this journal is based on Altmetric scores that are used as a quality indicator. That helps both readers and authors to verify publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication". Oncotarget website provides a full publications list with respective scores higher

  Oncotarget   Volume 11 ,   Issue 35   published " Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers " by Balhorn et, al. which reported that SH7139, the first of a series of selective high affinity ligand oncology drug candidates designed to target and bind to the HLA-DR proteins overexpressed by B-cell lymphomas, has demonstrated exceptional efficacy in the treatment of Burkitt lymphoma xenografts in mice and a safety profile that may prove to be unprecedented for an oncology drug. The aim of this study was to determine how frequently the HLA-DRs targeted by SH7139 are expressed by different subtypes of non-Hodgkin's lymphoma and by other solid cancers that have been reported to express HLA-DR. Binding studies conducted with SH7129, a biotinylated analog of SH7139, reveal that more than half of the biopsy sections obtained from patients with different types of non-Ho

When public refer to modern medicine, accuracy plays one of the most important roles and people’s lives are directly dependent on it. Hereby, any researches related to medicine are required to meet the highest standards. The issue nowadays is that any conclusions of researches can be shared online and used as a reference without being precisely checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this issue and tried to create an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been established back in 2010. The major principle of this journal is related to Altmetric scores that are used as a quality indicator. That assists both readers and authors to validate publications with Altmetric Article Reports that generate “real-time feedback containing data summary related to a particular publication". Oncotarget website demonstrates a full publications list with corresponding scores higher than 10

When people refer to modern medicine, accuracy plays one of the most important roles and human lives are directly dependent on it. Hence, any researches related to medicine are necessary to meet the highest standards. The challenge today is that any results of researches can be shared online and used as a reference without being properly verified and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this issue and attempted to come up with an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been established back in 2010. The key principle of this journal is based on Altmetric scores that are used as a quality measure. That allows both readers and authors to quality-check publications with Altmetric Article Reports that generate “real-time feedback containing data summary related to a particular publication". Oncotarget website has a full publications list with respective scores above 100 as well as rep

  The cover for issue 40 of Oncotarget features Figure 5, "miR-210 silences the proapoptosis member CASP8AP2," by Kling, et al. which reported that hypoxic Ewing's sarcoma cells release exosomes that promote sphere formation, a stem-like phenotype, in EWS cells by enhancing survival. Analysis of the hypoxic exosomal miRNA cargo identified a HIF-1α regulated miRNA, miR-210, as a potential mediator of sphere formation in cells exposed to hypoxic exosomes. The knockdown of HIF-1α in hypoxic EWS cells led to decreased exosomal miR-210 levels and reduced the capacity of hypoxic exosomes to form spheres. Inhibition of miR-210 in hypoxic spheres attenuated sphere formation and overexpression of miR-210 in normoxic spheres significantly enhanced the number of EWS spheres. Together, the findings in this Oncotarget study suggest that hypoxic exosomes promote stemness in EWS cells by delivering enriched miR-210 that is capable of down-regulating apoptotic pathways, resulting in t

When public mention contemporary medicine, precision plays one of the most important roles and human lives are literally dependent on it. Hence, any researches related to medicine are required to meet the top standards. The challenge nowadays is that any conclusions of researches can be published online and used as a reference without being precisely checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this issue and decided to create an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The main principle of this journal is related to Altmetric scores that are used as a quality indicator. That allows both readers and authors to validate publications with Altmetric Article Reports that generate “real-time feedback containing data summary related to a particular publication". Oncotarget website has a complete publications list with respective scores higher than 100 as wel

Oncotarget недавно опубликовал « Нацеливание на метаболизм рака молочной железы с помощью нового ингибитора синтеза митохондриального АТФ » Ким и др. в котором сообщается, что авторы показывают, что CADD522 ингибирует митохондриальное окислительное фосфорилирование, снижая скорость потребления кислорода митохондриями и продукцию АТФ в клетках рака груди человека независимым от RUNX2 образом. Ферментативная активность митохондриальной АТФ-синтазы подавлялась обработкой CADD522. Дифференциальная сканирующая флуориметрия также продемонстрировала взаимодействие α-субъединиц F1-АТФ-синтазы с CADD522. Эти результаты предполагают, что CADD522 может нацеливаться на ферментативные субъединицы F1 в комплексе АТФ-синтазы. CADD522 увеличивал уровни внутриклеточных активных форм кислорода, чему препятствовал MitoQ, антиоксидант, нацеленный на митохондрии, что позволяет предположить, что раковые клетки, подвергшиеся воздействию CADD522, могут повышать уровень ROS из митохондрий. В совокупности

When general population discuss today’s medicine, accuracy plays one of the most important roles and human lives are literally dependent on it. Hence, any researches related to medicine are necessary to comply with the highest standards. The problem nowadays is that any recommendations of researches can be posted online and used as a reference without being precisely checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this problem and tried to come up with an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been established back in 2010. The main principle of this journal is related to Altmetric scores that are used as a quality measure. That assists both readers and authors to verify publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication". Oncotarget website provides a complete publications list with respective s

When public refer to contemporary medicine, accuracy plays one of the most important roles and people’s lives are directly dependent on it. Hence, any researches pertaining to medicine are required to comply with the highest standards. The issue today is that any outcomes of researches can be published online and used as a reference without being properly verified and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and attempted to create an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been founded back in 2010. The major principle of this journal is related to Altmetric scores that are used as a quality indicator. That assists both readers and authors to verify publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication". Oncotarget website demonstrates a complete publications list with respective scores a